NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Xian Yihang Technology? Mail in a sample (US only) and let us test it.

Test my supply
71%
Finnrick rating
#344 of 419 Retatrutide vendors
15 of 22 classifiable tests passed
natural 68% · customers 4.8★ (9)
methodology · Purity focus
Finnrick analysis · Retatrutide

Xian Yihang Technology's Retatrutide signal is held down by repeated purity misses below 99.5%, not identity failures or fill breaches. Recent evidence is mixed: a 98.7% purity miss sits beside same-day 99.9% passes, with sparse batch IDs.

methodology →
vendor intelligence report
Vendor Intelligence Report: Xian Yihang Technology

Business-license, WHOIS and marketplace records tie TopXPeptide to a Xi’an Yihang entity, but not to the factory story its marketing suggests. The report follows white-label batch trails, YH lookalike brands and a public industrial-project claim that points elsewhere.

36 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.12
82%
8
2
Tirzepatide
$0.24
78%
28
3
Retatrutideselected
$0.40
71%
22
4
Ipamorelin
$1.30
62%
3
5
Semaglutide
$0.27
62%
4
6
BPC-157
-
60%
5
7
Tesamorelin
$1.71
51%
7
8
TB-500
-
41%
4
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%27 Jun 2025: 63%3 Jul 2025: 66%4 Aug 2025: 64%10 Sep 2025: 71%7 Oct 2025: 71%13 Oct 2025: 72%21 Oct 2025: 74%23 Oct 2025: 69%23 Oct 2025: 66%25 Nov 2025: 68%1 Jan 2026: 70%15 Jan 2026: 71%26 Feb 2026: 73%2 Mar 2026: 74%3 Mar 2026: 71%3 Mar 2026: 72%4 Mar 2026: 69%23 Apr 2026: 67%23 Apr 2026: 68%23 Apr 2026: 69%23 Apr 2026: 70%9 Jul 2026: 72%15 Nov 2026: current 71%63%70%71%Jun 25Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Xian Yihang Technology? Mail in a sample (US only) and let us test it.

Test my supply
Xian Yihang Technology Retatrutide test history
COA-backed lab tests
1-10 of 22

About Xian Yihang Technology test results from Finnrick

Xian Yihang Technology is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 8 peptides and 81 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Xian Yihang Technology peptides in this dataset are Semaglutide (4 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 81 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from Xian Yihang Technology? Mail in a sample (US only) and let us test it.

Test my supply